060280 — CUREXO Income Statement
0.000.00%
- KR₩629bn
- KR₩604bn
- KR₩56bn
Annual income statement for CUREXO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 42,795 | 64,991 | 72,882 | 55,531 | 74,532 |
| Cost of Revenue | |||||
| Gross Profit | 9,056 | 14,389 | 19,298 | 14,628 | 24,838 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 47,835 | 65,649 | 71,747 | 61,353 | 72,170 |
| Operating Profit | -5,040 | -658 | 1,135 | -5,822 | 2,362 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2,320 | -2,933 | -4,760 | -8,669 | 2,831 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,342 | -3,041 | -4,856 | -8,758 | 2,771 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2,342 | -3,041 | -4,856 | -8,758 | 2,771 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,342 | -3,041 | -4,856 | -8,758 | 2,771 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7.29 | -52.2 | -120 | -213 | 67.4 |
| Dividends per Share |